Subscribe to this journal
Advanced Search
 array:22 [
  "pii" => "S2173574309701406"
  "issn" => "21735743"
  "doi" => "10.1016/S2173-5743(09)70140-6"
  "estado" => "S300"
  "fechaPublicacion" => "2009-11-01"
  "aid" => "70140"
  "copyright" => "Sociedad Española de Reumatología and Colegio Mexicano de Reumatología"
  "copyrightAnyo" => "2009"
  "documento" => "simple-article"
  "crossmark" => 0
  "subdocumento" => "cor"
  "cita" => "Reumatol Clin. 2009;5:292-3"
  "abierto" => array:3 [
    "ES" => false
    "ES2" => false
    "LATM" => false
  ]
  "gratuito" => false
  "lecturas" => array:2 [
    "total" => 527
    "formatos" => array:3 [
      "EPUB" => 42
      "HTML" => 321
      "PDF" => 164
    ]
  ]
  "itemAnterior" => array:18 [
    "pii" => "S217357430970139X"
    "issn" => "21735743"
    "doi" => "10.1016/S2173-5743(09)70139-X"
    "estado" => "S300"
    "fechaPublicacion" => "2009-11-01"
    "aid" => "70139"
    "copyright" => "Sociedad Española de Reumatología and Colegio Mexicano de Reumatología"
    "documento" => "simple-article"
    "crossmark" => 0
    "subdocumento" => "cor"
    "cita" => "Reumatol Clin. 2009;5:291"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:2 [
      "total" => 498
      "formatos" => array:3 [
        "EPUB" => 37
        "HTML" => 338
        "PDF" => 123
      ]
    ]
    "en" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "Cost-effectiveness study of leflunomide versus methotrexate"
      "tienePdf" => "en"
      "tieneTextoCompleto" => 0
      "paginas" => array:1 [
        0 => array:1 [
          "paginaInicial" => "291"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Estudio coste-efectividad de leflunomida frente a metotrexato"
        ]
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Jordi Galván"
          "autores" => array:1 [
            0 => array:2 [
              "nombre" => "Jordi"
              "apellidos" => "Galván"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S217357430970139X?idApp=UINPBA00004M"
    "url" => "/21735743/0000000500000006/v1_201305061600/S217357430970139X/v1_201305061600/en/main.assets"
  ]
  "en" => array:9 [
    "idiomaDefecto" => true
    "titulo" => "Response of the author to the letter “Cost-effectiveness study of leflunomide versus methotrexate”"
    "tieneTextoCompleto" => 0
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "292"
        "paginaFinal" => "293"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Antonio J. García Ruiz, Ana C. Montesinos Gálvez, Lucía Pérez Costillas, Pablo Rebollo"
        "autores" => array:4 [
          0 => array:4 [
            "nombre" => "Antonio J."
            "apellidos" => "García Ruiz"
            "email" => array:1 [
              0 => "ajgr@uma.es"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:3 [
            "nombre" => "Ana C&#46;"
            "apellidos" => "Montesinos G&#225;lvez"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          2 => array:3 [
            "nombre" => "Luc&#237;a P&#233;rez"
            "apellidos" => "Costillas"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          3 => array:3 [
            "nombre" => "Pablo"
            "apellidos" => "Rebollo"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:2 [
          0 => array:3 [
            "entidad" => "Unidad de Farmacoeconom&#237;a e Investigaci&#243;n de Resultados en Salud&#44; Universidad de M&#225;laga&#44; M&#225;laga&#44; Spain"
            "etiqueta" => "<span class="elsevierStyleSup">a</span>"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "BAP Health Outcomes&#44; Oviedo&#44; Principado de Asturias&#44; Spain"
            "etiqueta" => "<span class="elsevierStyleSup">b</span>"
            "identificador" => "aff0010"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#42;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Respuesta del autor a la carta &#171;Estudio coste-efectividad de leflunomida frente a metrotexato&#187;"
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:8 [
            0 => array:3 [
              "identificador" => "bib1"
              "etiqueta" => "1&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Comparaci&#243;n de leflunomida y metotrexato subcut&#225;neo en el tratamiento de la artritis reumatoide&#58; una aproximaci&#243;n basada en el n&#250;mero de pacientes que es necesario tratar"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "J&#46;A&#46; Garc&#237;a Ruiz"
                            1 => "A&#46;C&#46; Montesinos G&#225;lvez"
                            2 => "L&#46; P&#233;rez Costillas"
                            3 => "P&#46; Rebollo"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.reuma.2008.11.007"
                      "Revista" => array:6 [
                        "tituloSerie" => "Reumatol Clin"
                        "fecha" => "2009"
                        "volumen" => "5"
                        "paginaInicial" => "66"
                        "paginaFinal" => "70"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21794646"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib2"
              "etiqueta" => "2&#46;"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Agencia de Evaluaci&#243;n de Tecnolog&#237;as Sanitarias de Andaluc&#237;a&#46; Gu&#237;a para la Incorporaci&#243;n de Nuevos F&#225;rmacos&#46; Apoyo a la toma de decisiones en los hospitales del Sistema Sanitario P&#250;blico de Andaluc&#237;a &#91;Internet&#93;&#46; Versi&#243;n 2&#46;0&#46; Sevilla&#58; AETSA&#59; 2004 &#91;consulted 6&#47;2&#47;2009&#93;&#46; Available from&#58; URL&#58; http&#58;&#47;&#47;www&#46;juntadeandalucia&#46;es&#47;salud&#47;orgdep&#47;aetsa&#47;pdf&#47;Gu&#237;a GINF v2&#46;pdf&#46;"
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib3"
              "etiqueta" => "3&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Cost-efectiveness analysis based on the numberneeded- to-treat&#58; Common sense or non-sense&#63;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "I&#46;S&#46; Kristiansen"
                            1 => "D&#46; Gyrd-Hansen"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/hec.797"
                      "Revista" => array:6 [
                        "tituloSerie" => "Health Econ"
                        "fecha" => "2004"
                        "volumen" => "13"
                        "paginaInicial" => "9"
                        "paginaFinal" => "19"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14724890"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib4"
              "etiqueta" => "4&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Limitaciones y falacias de la f&#243;rmula del &#8220;n&#250;mero de pacientes que ser&#225; necesario tratar&#8221;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "E&#46; Figueredo"
                            1 => "L&#46; Canosa"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:4 [
                        "tituloSerie" => "Med Clin &#40;Barc&#41;"
                        "fecha" => "1999"
                        "volumen" => "112"
                        "paginaInicial" => "36"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib5"
              "etiqueta" => "5&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis&#58; Results of a six-month&#44; multicenter&#44; randomized&#44; double-blind&#44; controlled&#44; phase IV trial"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46; Braun"
                            1 => "P&#46; K&#228;stner"
                            2 => "P&#46; Flaxenberg"
                            3 => "J&#46; W&#228;hrisch"
                            4 => "P&#46; Hanke"
                            5 => "W&#46; Demary"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/art.23144"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arthritis Rheum"
                        "fecha" => "2008"
                        "volumen" => "58"
                        "paginaInicial" => "73"
                        "paginaFinal" => "81"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18163521"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib6"
              "etiqueta" => "6&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Caveats to the use of parenteral methotrexate in the treatment of rheumatic disease"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "R&#46;K&#46; Moitra"
                            1 => "J&#46;M&#46; Ledingham"
                            2 => "R&#46;G&#46; Hull"
                            3 => "F&#46;C&#46; McCrae"
                            4 => "A&#46;L&#46; Thomas"
                            5 => "R&#46; Shaban"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1093/rheumatology/keh471"
                      "Revista" => array:6 [
                        "tituloSerie" => "Rheumatology"
                        "fecha" => "2005"
                        "volumen" => "44"
                        "paginaInicial" => "256"
                        "paginaFinal" => "257"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15637036"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib7"
              "etiqueta" => "7&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Parenteral methotrexate should be given before biological therapy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "S&#46;J&#46; Bingham"
                            1 => "M&#46;H&#46; Buch"
                            2 => "S&#46; Lindsay"
                            3 => "A&#46; Pollard"
                            4 => "J&#46; White"
                            5 => "P&#46; Emery"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1093/rheumatology/keg246"
                      "Revista" => array:6 [
                        "tituloSerie" => "Rheumatology"
                        "fecha" => "2003"
                        "volumen" => "42"
                        "paginaInicial" => "1009"
                        "paginaFinal" => "1010"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12869673"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib8"
              "etiqueta" => "8&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Economic comparison of leflunomide and methotrexate in patients with rheumatoid arthritis&#58; An evaluation based on a 1&#8211;year randomised controlled trial"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "A&#46; Maetzel"
                            1 => "V&#46; Strand"
                            2 => "P&#46; Tugwell"
                            3 => "G&#46; Wells"
                            4 => "C&#46; Bombardier"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Pharmacoeconomics"
                        "fecha" => "2002"
                        "volumen" => "20"
                        "paginaInicial" => "61"
                        "paginaFinal" => "70"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11817993"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/21735743/0000000500000006/v1_201305061600/S2173574309701406/v1_201305061600/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "8400"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Letters to the Editor"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/21735743/0000000500000006/v1_201305061600/S2173574309701406/v1_201305061600/en/main.pdf?idApp=UINPBA00004M&text.app=https://reumatologiaclinica.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574309701406?idApp=UINPBA00004M"
]
Share
November - December 2009 Response of the author to the letter “Cost-effectiveness study of leflunomide...
Journal Information
Previous article | Next article
Vol. 5. Issue 6.
Pages 292-293 (November - December 2009)
Export reference
Share
Share
Print
Download PDF
More article options
Statistics
Vol. 5. Issue 6.
Pages 292-293 (November - December 2009)
DOI: 10.1016/S2173-5743(09)70140-6
Full text access
Response of the author to the letter “Cost-effectiveness study of leflunomide versus methotrexate”
Respuesta del autor a la carta «Estudio coste-efectividad de leflunomida frente a metrotexato»
Visits
3418
Download PDF
Antonio J. García Ruiza,
Corresponding author
ajgr@uma.es

Corresponding author.
, Ana C. Montesinos Gálveza, Lucía Pérez Costillasa, Pablo Rebollob
a Unidad de Farmacoeconomía e Investigación de Resultados en Salud, Universidad de Málaga, Málaga, Spain
b BAP Health Outcomes, Oviedo, Principado de Asturias, Spain
This item has received
3418 Visits
Article information
Bibliography
Download PDF
Statistics
Full text is only aviable in PDF
References
[1.]
J.A. García Ruiz, A.C. Montesinos Gálvez, L. Pérez Costillas, P. Rebollo.
Comparación de leflunomida y metotrexato subcutáneo en el tratamiento de la artritis reumatoide: una aproximación basada en el número de pacientes que es necesario tratar.
Reumatol Clin, 5 (2009), pp. 66-70
http://dx.doi.org/10.1016/j.reuma.2008.11.007 | Medline
[2.]
Agencia de Evaluación de Tecnologías Sanitarias de Andalucía. Guía para la Incorporación de Nuevos Fármacos. Apoyo a la toma de decisiones en los hospitales del Sistema Sanitario Público de Andalucía [Internet]. Versión 2.0. Sevilla: AETSA; 2004 [consulted 6/2/2009]. Available from: URL: http://www.juntadeandalucia.es/salud/orgdep/aetsa/pdf/Guía GINF v2.pdf.
[3.]
I.S. Kristiansen, D. Gyrd-Hansen.
Cost-efectiveness analysis based on the numberneeded- to-treat: Common sense or non-sense?.
Health Econ, 13 (2004), pp. 9-19
http://dx.doi.org/10.1002/hec.797 | Medline
[4.]
E. Figueredo, L. Canosa.
Limitaciones y falacias de la fórmula del “número de pacientes que será necesario tratar”.
Med Clin (Barc), 112 (1999), pp. 36
[5.]
J. Braun, P. Kästner, P. Flaxenberg, J. Währisch, P. Hanke, W. Demary, et al.
Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: Results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial.
Arthritis Rheum, 58 (2008), pp. 73-81
http://dx.doi.org/10.1002/art.23144 | Medline
[6.]
R.K. Moitra, J.M. Ledingham, R.G. Hull, F.C. McCrae, A.L. Thomas, R. Shaban, et al.
Caveats to the use of parenteral methotrexate in the treatment of rheumatic disease.
Rheumatology, 44 (2005), pp. 256-257
http://dx.doi.org/10.1093/rheumatology/keh471 | Medline
[7.]
S.J. Bingham, M.H. Buch, S. Lindsay, A. Pollard, J. White, P. Emery.
Parenteral methotrexate should be given before biological therapy.
Rheumatology, 42 (2003), pp. 1009-1010
http://dx.doi.org/10.1093/rheumatology/keg246 | Medline
[8.]
A. Maetzel, V. Strand, P. Tugwell, G. Wells, C. Bombardier.
Economic comparison of leflunomide and methotrexate in patients with rheumatoid arthritis: An evaluation based on a 1–year randomised controlled trial.
Pharmacoeconomics, 20 (2002), pp. 61-70
Medline
Copyright © 2009. Sociedad Española de Reumatología and Colegio Mexicano de Reumatología

Subscribe to our newsletter

Recommended
articles
Use of parenteral methotrexate in rheumatic diseases: A...
Reumatol Clin. 2022;18:207-26
Safety and survival associated with biologic therapies:...
Reumatol Clin. 2020;16P2:396-404
Publish in
Reumatología Clínica
Free access articles
Efficacy of psychological interventions to reduce anxiety...
Reumatol Clin. 2024;20:440-51
Controversy about the use and financing of SYSADOA for...
Reumatol Clin. 2024;20:416-22
Real-world apremilast use in biologic-naïve psoriatic...
Reumatol Clin. 2024;20:24-31
Download PDF
Idiomas
Reumatología Clínica (English Edition)
Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?